Sort by
Search results
Protac® Protein C Activator
For activation of protein C.
vWF Deficient Plasma
For any in vitro protocol or research study where a source of vWF deficient plasma is required.
Protein S Deficient Plasma
For any in vitro protocol or research study where a source of human protein S deficient plasma is required.
Protein C Deficient Plasma
For any in vitro protocol or research study where a source of human protein C deficient plasma is required.
Factor XII Deficient Plasma
Measurement of factor XII (FXII or factor hageman) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXII deficient plasma is required.
Factor XI Deficient Plasma
Measurement of Factor XI (FXI or factor rosenthal) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXI deficient plasma is required
Factor XI Deficient Plasma
Measurement of factor XI (FXI or factor rosenthal) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXI deficient plasma is required
Factor X Deficient Plasma
Measurement of factor X (FX or stuart factor) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FX deficient plasma is required
Factor IX Deficient Plasma
Measurement of factor IX (FIX) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FIX deficient plasma is required.
Factor VIII Deficient Plasma
Measurement of factor VIII (FVIII) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FVIII deficient plasma is required.